eli lilly retatrutide phase 3 trial Experimental Drug Shows Surgery-Level Weight Loss in Eli Lilly infiltrates anti-obesity market
Description
Further long-term research is required to ensure these medications guide patients toward healthy balance rather than alternative forms of eating disorders
Other than the gastrointestinal side effects [11], tirzepatide may rarely contribute to sinus tachycardia, acute kidney injury secondary to dehydration, pancreatitis, cholelithiasis, and cholecystitis
You cant do this on Hers
Treatment of people with type 1 diabetes with semaglutide or tirzepatide relevant in the future
Key takeaways Nearly 3 in 4 UK GLP-1 users have felt more confident since starting the medication
doi: 10.1046/j.1365-2346.2000.00609.x
